CardioFocus

At #AFSymposium2026, QuickShot™ Nav demonstrated magnetic integration with LUMA Vision’s VERAFEYE™ system, enabling precise, real-time visualization and navigation during PFA.

Note: QuickShot™ Nav is investigational and not approved for commercial use.

AF Symposium 2026 is here and CardioFocus is energized to be on the ground in Boston with our team!

📍Global IDE site recruitment in our tech suite (MR11)
🧬Late-breaking presentation tonight at 5:10 PM by Dr. Vivek Reddy on VISION AF first-in-human data

#EPeeps #AFS2026 #PFA

AF Symposium 2026 starts this week—and CardioFocus is bringing new data, new studies, and a growing PFA portfolio to Boston!⚡

🔗Read the full press release: lnkd.in/gDQM_gMN..
📍Visit us at our Tech Suite MR11

#EPeeps #AFSymposium2026

Congrats to St. Anne's University Hospital Brno for their first cases in the CardioFocus CE Mark pivotal trial evaluating the QuickShot™ Nav PFA Catheter & CardioWave™ PFA System.

QuickShot™ Nav and CardioWave™ are investigational and not approved for commercial use.

Excited to have enrolled the first patients at Nemocnice Na Homolce in our CE Mark pivotal trial of the QuickShot™ Nav PFA Catheter and CardioWave™ PFA System.

Note: The QuickShot™ Nav and CardioWave™ are investigational and not approved for commercial use.